The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature

Parkinsonism and Related Disorders

Volumn 22, Issue , 2016, Pages S166-S170

  Veselý, Branislav ^a   Rektor, Ivan ^b  

^a Institute of Clinical Microbiology   (Slovakia)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cerebrovascular disease; Dementia; Mild cognitive impairment; Parkinson's disease; White matter lesions

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE ASSESSMENT; COGNITIVE DEFECT; DEMENTIA; DENERVATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC DENERVATION; EXECUTIVE FUNCTION; FRONTAL LOBE DYSFUNCTION; HUMAN; LANGUAGE DISABILITY; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; UNITED KINGDOM BRAIN BANK CRITERIA; VASCULAR RISK FACTOR; VERBAL FLUENCY; WHITE MATTER LESION; ANIMAL; BRAIN; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES; PSYCHOLOGY; WHITE MATTER;

ANIMALS; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; WHITE MATTER;

EID: 84947868802     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.09.019     Document Type: Article

References (30)

1. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MRI signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987, 149:351-356.
2. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., Steinling M., Valk J. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 1993, 114:7-12.
3. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjogren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P. European task force on age-related white matter changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
4. de Boer R., Vrooman H.A., van der Lijn F., Vernooij M.W., Ikram M.A., van der Lugt A., Breteler M.M., Niessen W.J. White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage 2009, 45:1151-1161.
5. Choi S.A., Evidente V.G., Caviness J.N., Shill H.A., Sabbagh M.N., Connor D.J., Hentz J.G., Adler C.H., Beah T.G. Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?. Acta Neuropathol. 2010, 119:147-149.
6. Beyer M.K., Aarsland D., Greve O.J., Larsen J.P. Visual rating of white matter hyperintensities in Parkinson's disease. Mov. Disord. 2006, 21:223-229.
7. Meyer J.S., Huang J., Chowdhury M.H. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J. Neurol. Sci. 2007, 257:97-104.
8. Santangelo G., Vitale C., Trojano L., De Gaspari D., Bilo L., Antonini A., Barone P. Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov. Disord. 2010, 25:50-56.
9. Lee S.J., Kim J.S., Yoo J.Y., Song I.U., Kim B.S., Jung S.L., Yang D.W., Kim Y.I., Jeong D.S., Lee K.S. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis. Assoc. Disord. 2010, 24:227-233.
10. Ng A., Chew I., Tay K.Y., Au W.L., Tan L., Kandiah N. White matter disease adversely influences cognition in idiopathic Parkinson's disease. Alzheimer's Dementia 2012, 8:171-172.
11. Sławek J., Roszmann A., Robowski P., Dubaniewicz M., Sitek E.J., Honczarenko K., Gorzkowska A., Budrewicz S., Mak M., Golab-Janowska M., Koziorowska-Gawron E., Drozdik M., Kurzawski M., Bandurski T., Bialecka M. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors. Neurodegener. Dis. 2013, 12(1):1-12.
12. Kandiah N., Mak E., Ng A., Huang S., Au W.L., Sitoh Y.Y., Tan L.C. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Park. Relat. Disord. 2013, 19:680-683.
13. Sławek J., Wieczorek D., Derejko M., Dubaniewicz M., Brockhuis B., Sitek E., Wilczewska L., Roszmann A., Lass P. The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Neurol. Neurochir. Pol. 2008, 42:505-512.
14. Dalaker T.O., Larsen J.P., Dwyer M.G., Aarsland D., Beyer M.K., Alves G., Bronnick K., Tysnes O.B., Zivadinov R. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage 2009, 47:2083-2089.
15. González-Redondo R., Toledo J., Clavero P., Lamet I., Garcia-Garcia D., Garcia-Eulate R., Martinez-Lage P., Rodriguez-Oroz M.C. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease. Eur. J. Neurol. 2012, 19:1100-1107.
16. Kelly V.E., Johnson C.O., McGough E.L., Shumway-Cook A., Horak F.B., Chung K.A., Espay A.J., Revilla F.J., Devoto J., Wood-Siverio C., Factor S.A., Cholerton B., Edwards K.L., Peterson A.L., Quinn J.F., Montine T.J., Zabetian C.P., Leverenz J.B. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease. Park. Relat. Disord. 2015, 21:692-697.
17. Aarsland D., Perry R., Brown A., Larsen J.P., Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community- based study. Ann. Neurol. 2005, 58:773-776.
18. Jellinger K.A. The morphological basis of mental dysfunction in Parkinson's disease. J. Neurol. Sci. 2006, 248:167-172.
19. Bohnen N.I., Frey K.A. Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders. Mol. Imaging Biol. 2007, 9:243-257.
20. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
21. Jellinger K.A., Seppi K., Wenning G.K., Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J. Neural Transm. 2002, 109:329-339.
22. Theilmann R.J., Reed J.D., Song D.D., Huang M.X., Lee R.R., Litvan I., Harrington D.L. White-matter changes correlate with cognitive functioning in Parkinson's disease. Front. Neurol. 2013, 4:1-8.
23. Au R., Massaro J.M., Wolf P.A., Young M.E., Beiser A., Seshadri S., D'Agostino R.B., DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 2006, 63:246-250.
24. Rektor I., Goldemund D., Sheardová K., Rektorová I., Michálková Z., Dufek M. Vascular pathology in patients with idiopathic Parkinson's disease. Park. Relat. Disord. 2009, 15:24-29.
25. Rektor I., Goldemund D., Bednařík P., Sheardová K., Michálková Z., Telecká S., Dufek M., Rektorová I. Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease. Mov. Disord. 2012, 27:1169-1172.
26. Guan J., Pavlovic D., Dalkie N., Waldvogel H.J., O'Carroll S.J., Green C.R., Nicholson L.F. Vascular degeneration in Parkinson's disease. Brain Pathol. 2013, 23:154-164.
27. Rosenberg G.A., Bjerke M., Wallin A. Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke 2014, 45:1531-1538.
28. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case control study. Stroke 2006, 37:1184-1188.
29. Kandiah N., Hani Zainal N,Narasimhalu K., Chander R.J., Ng A., Mak E., Au WL,Sitoh Y.Y., Nadkarni N., Tan L.C.S. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease. Park. Relat. Disord. 2014, 20:1203-1208.
30. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., Geurts J.J. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatry 2011, 82(2):126-135.